Wolverine Trading, LLC Vaxart, Inc. Put Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$2.09 - $4.5 $7,941 - $17,100	-3,800 Reduced 16.1%	19,800 $42,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $5.28 $1,350 - $2,640	500 Added 2.16%	23,600 $83,000
Q1 2022 May 16, 2022	BUY	$4.29 - $6.64 $99,099 - $153,384	23,100 New	23,100 $115,000
Q4 2021 Feb 14, 2022	SELL	$5.77 - $7.96 $394,090 - $543,668	-68,300 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$6.67 - $9.8 $180,757 - $265,580	-27,100 Reduced 28.41%	68,300 $548,000
Q2 2021 Aug 06, 2021	BUY	$5.06 - $10.78 $289,432 - $616,616	57,200 Added 149.74%	95,400 $787,000
Q1 2021 May 14, 2021	BUY	$5.64 - $23.33 $215,448 - $891,205	38,200 New	38,200 $221,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.